Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.
about
Pharmacological targeting of the serotonergic system for the treatment of obesityChronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese ratsConformational analysis of the anti-obesity drug lorcaserin in water: how to take advantage of long-range residual dipolar couplings.Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndromeCurrent and future drug targets in weight managementThe utility of animal models to evaluate novel anti-obesity agents.Hypothalamic Ahi1 mediates feeding behavior through interaction with 5-HT2C receptor.Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.Evaluating pharmacological models of high and low anxiety in sheepEffect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude miceA review of late-stage CNS drug candidates for the treatment of obesity.HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.Association between serotonin 5-HT-2C receptor gene (HTR2C) polymorphisms and obesity- and mental health-related phenotypes in a large population-based cohort.Towards a more practical attention bias test to assess affective state in sheep.A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients.Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis.Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective [Formula: see text] agonists.Functional Interplay between Small Non-Coding RNAs and RNA Modification in the Brain.
P2860
Q24658013-26076A8C-45A0-4272-AC67-947E46647ADBQ24675513-471DD4B8-8722-43B6-BDEE-18C5BF07E7F6Q30672639-D6D8A447-9DDD-4BC6-A9A9-BA95F1D65DE4Q34669261-486CCA67-2189-4C93-AEB9-80C9BE06F33AQ35089784-6E0928D7-46AD-4315-853F-3514A6BF4AA8Q35589958-51907C60-6F3B-46BD-9AD1-6100D46423AEQ35694089-6D944F83-FFDF-4759-A1FF-436D6F911EC7Q35844223-A709B4ED-CCBF-485D-AF28-124E31CBB993Q36402156-612F6282-E7DB-412E-8F98-75554F032048Q37316686-D90970A0-6865-432D-A773-7206DA46E786Q37992857-0171DCD1-019B-474C-B25A-251AE7725288Q38242739-30C95A6F-FA73-4DA8-BC3D-D400F4126F42Q38842714-F747AF8E-B324-4760-BDA6-1299FB0F24B5Q43197092-EC979A94-F058-414E-AD1D-8EAFA5CEB926Q47223800-B650C9A0-EE09-4C9B-9A7F-7208909A1858Q47242918-F08D5912-D01A-41F2-9A33-5A4D6D2473F6Q47402954-359ADD77-F4BA-4071-AF41-2B65E4371864Q53251686-959C6BC3-C701-4A38-B9C1-A7388570F11AQ55668403-E3FC789F-C310-4BAB-84B7-C25CF62A18D0
P2860
Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Oral administration of the 5-H ...... sult of maintained hypophagia.
@en
Oral administration of the 5-H ...... sult of maintained hypophagia.
@nl
type
label
Oral administration of the 5-H ...... sult of maintained hypophagia.
@en
Oral administration of the 5-H ...... sult of maintained hypophagia.
@nl
prefLabel
Oral administration of the 5-H ...... sult of maintained hypophagia.
@en
Oral administration of the 5-H ...... sult of maintained hypophagia.
@nl
P2093
P2860
P1433
P1476
Oral administration of the 5-H ...... esult of maintained hypophagia
@en
P2093
G A Kennett
L J Webster
M J Bickerdike
S P Vickers
P2860
P2888
P304
P356
10.1007/S00213-002-1378-6
P577
2003-04-11T00:00:00Z